Connect with our Cambridge, MA research team, explore licensing opportunities for our CRISPR Cas24 and mRNA delivery platforms, or submit academic partnership proposals.
💼 Strategic Asset Acquisition Inquiries
Direct inquiries regarding domain ownership and intellectual portfolio transfer (Valuation: 1 ETH) to acquisition@biomodifying.com.
Submit a Research or Partnership Inquiry
Thank You! Your Request Has Been Received.
Our campaign engineers are reviewing your setup. While our dedicated portal gets configured, we recommend exploring our trusted automation partner Skylead — the all-in-one Smart Email & LinkedIn outreach platform.
Explore Skylead Free Trial→
Redirecting to partner site in 5s...
Thank you! Your message has been sent successfully.
Security check failed. Please solve the math equation correctly.